Cargando…
Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
Recent accumulating genomic and proteomic data suggested that decreased expression of phenazine biosynthesis-like domain-containing protein (PBLD) was frequently involved in hepatocellular carcinoma (HCC). However, there is lack of systematical investigation focusing on its expression pattern, clini...
Autores principales: | Li, Aimin, Yan, Qun, Zhao, Xinmei, Zhong, Jietao, Yang, Haiyun, Feng, Zhiqiang, Du, Yanlei, Wang, Yadong, Wang, Zenan, Wang, Hong, Zhou, Yongjian, Liu, Side, Nie, Yuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808015/ https://www.ncbi.nlm.nih.gov/pubmed/26594798 |
Ejemplares similares
-
PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells
por: Han, Lu, et al.
Publicado: (2022) -
Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1
por: Wu, Jiansong, et al.
Publicado: (2019) -
Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling
por: Chen, Shengbo, et al.
Publicado: (2021) -
CPEB3 functions as a tumor suppressor in colorectal cancer via JAK/STAT signaling
por: Fang, Yuxin, et al.
Publicado: (2020) -
LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer
por: Shi, Shengli, et al.
Publicado: (2020)